![Deniz Can Guven: We reviewed the available evidence regarding ICI use in patients with frailty](https://oncodaily.com/pub/uploads/2024/02/Deniz-Can-Guven2-e1710600585598.jpg)
Photo taken from Deniz Can Guven/X
Mar 16, 2024, 10:49
Deniz Can Guven: We reviewed the available evidence regarding ICI use in patients with frailty
Deniz Can Guven, Medical Oncologist at , recently shared on X/Twitter:
“Out in Journal of Geriatric Oncology.
We reviewed the available evidence regarding ICI use in patients with frailty.
Take home points:
- The available studies mostly used ECOG as a frailty surrogate.
- No increase in irAEs with frailty.
- Shortened OS in frailty-Mechanism.
- Need for more studies incorporating CGA to assess real impact.”
Source: Deniz Can Guven/X